Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

NCT00853125 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Kidney Cancer

Interventions

BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: sunitinib malate

Sponsor

Rutgers, The State University of New Jersey

Collaborators

[object Object]
[object Object]